Absorption |
Blood-Brain Barrier | BBB+ | 0.7225 |
Human Intestinal Absorption | HIA+ | 0.8992 |
Caco-2 Permeability | Caco2+ | 0.5589 |
P-glycoprotein Substrate | Substrate | 0.7150 |
P-glycoprotein Inhibitor | Non-inhibitor | 0.8482 |
Non-inhibitor | 0.8708 |
Renal Organic Cation Transporter | Non-inhibitor | 0.7235 |
Distribution |
Subcellular localization | Mitochondria | 0.7549 |
Metabolism |
CYP450 2C9 Substrate | Non-substrate | 0.7633 |
CYP450 2D6 Substrate | Non-substrate | 0.8769 |
CYP450 3A4 Substrate | Substrate | 0.5819 |
CYP450 1A2 Inhibitor | Non-inhibitor | 0.7003 |
CYP450 2C9 Inhibitor | Non-inhibitor | 0.8532 |
CYP450 2D6 Inhibitor | Non-inhibitor | 0.9398 |
CYP450 2C19 Inhibitor | Non-inhibitor | 0.8745 |
CYP450 3A4 Inhibitor | Non-inhibitor | 0.8180 |
CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.8486 |
Excretion |
Toxicity |
Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.8995 |
Non-inhibitor | 0.8646 |
AMES Toxicity | Non AMES toxic | 0.9200 |
Carcinogens | Non-carcinogens | 0.9523 |
Fish Toxicity | High FHMT | 0.9974 |
Tetrahymena Pyriformis Toxicity | High TPT | 0.5114 |
Honey Bee Toxicity | High HBT | 0.8204 |
Biodegradation | Not ready biodegradable | 0.9946 |
Acute Oral Toxicity | IV | 0.4123 |
Carcinogenicity (Three-class) | Non-required | 0.4329 |